Statin shapes inflamed tumor microenvironment and enhances immune checkpoint blockade in non–small cell lung cancer
Immune checkpoint blockade (ICB) therapy has achieved breakthroughs in the treatment of advanced non–small cell lung cancer (NSCLC). Nevertheless, the low response due to immuno-cold (i.e., tumors with limited tumor-infiltrating lymphocytes) tumor microenvironment (TME) largely limits the applicatio...
שמור ב:
| Principais autores: | , , , , , , , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
American Society for Clinical investigation
2022-09-01
|
| סדרה: | JCI Insight |
| נושאים: | |
| גישה מקוונת: | https://doi.org/10.1172/jci.insight.161940 |
| תגים: |
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|
